- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (184)
- Timeline of Article Publication (3)
- Authors Evaluation (1)
- Article Quality Tracking (1)
- Reference Citation Analysis (5)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4224)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 20, 2024 (publication date) through May 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Oey O, Wijaya W, Redfern A. Eribulin in breast cancer: Current insights and therapeutic perspectives. World J Exp Med 2024; 14(2): 92558 [PMID: 38948420 DOI: 10.5493/wjem.v14.i2.92558] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315X/full/v14/i2/92558.htm |
| Number | Citing Articles |
| 1 |
Herleeyana Meriyani, Dwi Arymbhi Sanjaya, Rr. Asih Juanita, Nyoman Budiartha Siada, Nurul Chusna, Florentina Gabriela Ketupapa. Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review. Borneo Journal of Pharmacy 2025; 8(1): 33 doi: 10.33084/bjop.v8i1.7913
|